| Literature DB >> 31820364 |
Stephen A Banse1, Mark Lucanic2, Christine A Sedore1, Anna L Coleman-Hulbert1, W Todd Plummer2, Esteban Chen3, Jason L Kish2, David Hall2, Brian Onken3, Michael P Presley2, E Grace Jones1, Benjamin W Blue1, Theo Garrett2, Mark Abbott3, Jian Xue3, Suzhen Guo3, Erik Johnson1, Anna C Foulger2, Manish Chamoli2, Ron Falkowski3, Ilija Melentijevic3, Girish Harinath3, Phu Huynh3, Shobhna Patel3, Daniel Edgar2, Cody M Jarrett1, Max Guo4, Pankaj Kapahi2, Gordon J Lithgow5, Monica Driscoll6, Patrick C Phillips7.
Abstract
The goal of the Caenorhabditis Intervention Testing Program is to identify robust and reproducible pro-longevity interventions that are efficacious across genetically diverse cohorts in the Caenorhabditis genus. The project design features multiple experimental replicates collected by three different laboratories. Our initial effort employed fully manual survival assays. With an interest in increasing throughput, we explored automation with flatbed scanner-based Automated Lifespan Machines (ALMs). We used ALMs to measure survivorship of 22 Caenorhabditis strains spanning three species. Additionally, we tested five chemicals that we previously found extended lifespan in manual assays. Overall, we found similar sources of variation among trials for the ALM and our previous manual assays, verifying reproducibility of outcome. Survival assessment was generally consistent between the manual and the ALM assays, although we did observe radically contrasting results for certain compound interventions. We found that particular lifespan outcome differences could be attributed to protocol elements such as enhanced light exposure of specific compounds in the ALM, underscoring that differences in technical details can influence outcomes and therefore interpretation. Overall, we demonstrate that the ALMs effectively reproduce a large, conventionally scored dataset from a diverse test set, independently validating ALMs as a robust and reproducible approach toward aging-intervention screening.Entities:
Keywords: Automation; CITP; Caenorhabditis elegans; Lifespan; Lifespan machine; Thioflavin T
Mesh:
Substances:
Year: 2019 PMID: 31820364 PMCID: PMC6925072 DOI: 10.1007/s11357-019-00108-9
Source DB: PubMed Journal: Geroscience ISSN: 2509-2723 Impact factor: 7.713
Fig. 1Survival differences among C. elegans, C. briggsae, and C. tropicalis species are reported similarly by manual and automated lifespan analysis. a, c, e Comparison of lifespans from manual and ALM survival analyses. Median lifespans from eight C. elegans (a), eight C. briggsae (c), and six C. tropicalis (e) strains. Strains are ordered from shortest to longest average median lifespan in the manual assays. Each point represents the median lifespan from an individual plate trial conducted at one of the three CITP sites (Blue-Buck Institute, Green-Oregon and Red-Rutgers); all sites contributed three replicates of three plates tested/trial; the bars represent the mean +/− the standard error of the mean. For the manual data (open circles) ~ 35 animals were used to initiate each plate; for the ALM data (closed circles) ~ 50 animals were used to initiate each plate to account for worm loss in initial transfers to give a similar yield as in the manual assays. Asterisks represent p values (****p < 0.0001, *** p < 0.001, ** p < 0.01 and * p < 0.05) from the CPH model when comparing the lifespans measured by ALM versus manual assay. Summaries of the parent data used to generate these graphs are included in Online Resource 1. b, d, f Survivorship curves from data of combined trials for all C. elegans (b), C. briggsae (d), and C. tropicalis (f) strains. Manual data are from Lucanic et al. (2017).
Comparison of reproducibility of longevity estimates from manual and automated lifespan assays within and between labs for the baseline analysis of 22 strains across three species with no added compounds. Results for manual assays are from Lucanic et al. (2017)
| Source of variation | Manual assays | Automated assays |
|---|---|---|
| Genetic variation | 19.7 | 21.7 |
| Among species | 11.7 | 10.4 |
| Among strains w/in species | 8.0 | 11.3 |
| Reproducibility among labs | 7.5 | 9.4 |
| Among labs | 0.0 | 1.9 |
| Lab × species | 0.6 | 0.6 |
| Lab × strain | 6.9 | 6.9 |
| Reproducibility within labs | 15.4 | 10.5 |
| Among experimenters or scanners | 0.0 | 0.0 |
| Among trials w/in lab | 9.3 | 2.5 |
| Among plates w/in trials | 6.1 | 8 |
| Individual variation | 57.4 | 58.3 |
| Total | 100.0 | 100.0 |
| Total number of observations | 26,333 | 13,498 |
Confidence intervals were only computable for the manual assays
Fig. 2.ALM lifespan analysis does not exhibit the strong bimodal distribution of lifespan curves observed in manual assays. Survivorship curves from C. briggsae strains AF16 (a), HK104 (b), and JU1264 (c) are presented. Data were generated by manual lifespan and ALM analysis at all three CITP sites. The qualitatively bimodality of survivorship curves observed in manual analysis in at least two of the three independent sites for each of the C. briggsae strains does not stand out in the ALM data set. Manual data are from Lucanic et al. (2017)
Fig. 3Several lifespan compound interventions are reported similarly by manual and ALM lifespan analysis. The change in median lifespan under adult exposure to NP1 (a), propyl gallate (b), or resveratrol (c) are shown for three C. elegans (N2, JU775, and MY16) and C. briggsae (AF16, JU1348, and HK104) strains. Each point represents the change in median lifespan from an individual plate trial relative to the specific control conducted. The bars represent the mean +/− the standard error of the mean. Replicates were generated at the three CITP sites (Blue-Buck Institute, Green-Oregon and Red- Rutgers). Lifespans were measured by both manual (open circles) and ALM (closed circles) survival analyses. Asterisks represent p values (****p < 0.0001, *** p < 0.001, ** p < 0.01 and * p < 0.05) from the CPH model when comparing the lifespans under compound exposure versus the lifespans exposed to the vehicle control. Summaries of the parent data used to generate these graphs are included in Online Resource 10
Fig. 4Thioflavin T lifespan effects are reversed by light exposure in ALM analysis. Changes in median lifespan under adult exposure to thioflavin T (a) or α-ketoglutarate (b) are presented. Each point represents the percent difference in median lifespan from an individual plate trial relative to the control. The bars represent the mean +/− the standard error of the mean. Lifespans were measured by both manual (open circles) and ALM (closed circles) survival analyses. a Median lifespans were extended to variable degrees in all strains under thioflavin T exposure when measured using manual analysis, while ALM analysis gave consistently shorter median lifespans. Automated analysis with filtered light (closed diamonds) restored lifespan extension of thioflavin T for all strains except AF16 and JU1348 where filtering eliminated the reduction in lifespan from thioflavin T exposure while not reaching statistical significance for lifespan extension. b α-Ketoglutarate extended median lifespan in C. elegans strains in manual lifespan analyses, while no lifespan extension was observed in ALM analysis. Filtering the light during ALM analysis did not restore lifespan extension under α-ketoglutarate exposure. Asterisks represent p values (****p < 0.0001, *** p < 0.001, ** p < 0.01 and * p < 0.05) from the CPH model when comparing the lifespans under compound exposure versus the lifespans exposed to the vehicle control
Comparison of reproducibility of longevity estimates for manual and automated assays for pharmacological intervention for three different compounds (plus controls) for six strains across two species. Results for α-ketoglutarate and Thioflavin T are excluded from this analysis. Variance estimates for the compound trials are the averages across all compounds as estimated from a single general linear model. Estimates for manual assays are derived from Lucanic et al. (2017) for the subset of compounds used in this study
| Source of variation | Manual assays | Automated assays |
|---|---|---|
| Genetic variation | 44.9 | 33.1 |
| Among species | 32.5 | 12.8 |
| Among strains w/in species | 7.1 | 13.3 |
| Species × compound | 3.2 | 5.1 |
| Strain × Compound | 2.0 | 2.0 |
| Reproducibility among labs | 0.7 | 8.3 |
| Among labs | 0.0 | 0.0 |
| Lab × species | 0.4 | 0 |
| Lab × strain | 0.2 | 8.2 |
| Lab × compound | 0.0 | 0.1 |
| Reproducibility within labs | 8.8 | 8.3 |
| Among experimenters or scanners | 1.5 | 0.0 |
| Among trials w/in lab | 2.2 | 2.8 |
| Among plates w/in trials | 5.1 | 5.5 |
| Individual variation | 45.7 | 50.3 |
| Total | 100.0 | 100.0 |
| Total number of observations | 15,683 | 8846 |
Confidence intervals were only computable for the manual assays
Fig. 5Light filtering during ALM analysis changes late life survivorship. Survivorship curves for ALM assays with (dashed line) or without (solid line) light filtering for three C. elegans (N2 p < 0.001, JU775 p = 0.004, and MY16 p < 0.001) and three C. briggsae (AF16 p = 0.051, JU1348 p = 0.001, and HK104 p < 0.001) strains. The p values were calculated using the CPH model when comparing the lifespans measured with versus without light filtering (see Materials and methods)